Skip to main content
  • About
  • News & Events
  • Careers
  • Contact
  • Subscribe
FR
Canada’s Drug Agency | Drugs, Health Technologies and Systems.
  • Find Reports
    • Programs & Initiatives
      • Aging in Place
      • Appropriate Use
      • Canadian Medical Imaging Inventory
      • Drugs for Rare Diseases
      • Emergency Department Overcrowding
      • Health Technology Reviews
      • Horizon Scans
      • Post-Market Drug Evaluation
      • Reimbursement Reviews
      • Scientific Advice
    • Methods
      • Conflict of Interest
      • Methodological Guidelines
      • Program Procedures
    • Tools & Publications
      • Common Acronyms
      • Evidence Bundles
      • HTA Excel Tools
      • Finding the Evidence: Literature Searching Tools in Support of Systematic Reviews
      • Canadian Journal of Health Technologies
    • Provide Input
      • Current Opportunities
      • Instructions
      • Procedures & Templates
    • Engage
      • Sponsor a Reimbursement Review
      • Request Scientific Advice
      • Request an Evidence Review
    • Community Involvement
      • Collaboration and Outreach
      • Patient Groups
      • Pan-Canadian Collaborative
Canada’s Drug Agency | Drugs, Health Technologies and Systems.
FR
  • Find Reports
  • Our Work
    • Programs & Initiatives
      • Advisory Panel: Pan-Canadian Prescription Drug List
      • Aging in Place
      • Appropriate Use
      • Canadian Medical Imaging Inventory
      • Drugs for Rare Diseases
      • Emergency Department Overcrowding
      • Health Technology Reviews
      • Horizon Scans
      • Post-Market Drug Evaluation
      • Reimbursement Reviews
      • Scientific Advice
    • Methods
      • Conflict of Interest
      • Methodological Guidelines
      • Program Procedures
    • Tools & Publications
      • Common Acronyms
      • Evidence Bundles
      • HTA Excel Tools
      • Finding the Evidence: Literature Searching Tools in Support of Systematic Reviews
      • Canadian Journal of Health Technologies
  • Get Involved
    • Provide Input
      • Current Opportunities
      • Instructions
      • Procedures & Templates
    • Engage
      • Sponsor a Reimbursement Review
      • Request Scientific Advice
      • Request an Evidence Review
    • Community Involvement
      • Collaboration and Outreach
      • Patient Groups
      • Pan-Canadian Collaborative
  • About
  • News & Events
  • Careers
  • Contact
  • Subscribe

Resources

  1. Home
  2. Resources
  • Resources
    • Aging in Place
    • Canadian Medical Imaging Inventory
      • The Canadian Medical Imaging Inventory 2019 - 2020
      • In Brief: Canadian Medical Imaging Inventory: 2019-2020
      • Executive Summary - CMII 2019-2020
    • Drugs for Rare Diseases
    • Stakeholder Consultation
    • Evidence Bundles
    • Pan-Canadian Advisory Panel Members
    • Emergency Department Overcrowding
    • FAQs
    • Finding the Evidence: Literature Searching Tools in Support of Systematic Reviews
      • Grey Matters: a practical tool for searching health-related grey literature
      • PRESS Peer Review of Electronic Search Strategies
      • Search Filters Database
      • COVID-19 Search Strings
      • COVID-19 Vaccine Grey Literature Resources
      • COVID-19 Grey Literature Resources
    • HTA Excel Tools
    • Post-Market Drug Evaluation (PMDE) Program
      • PMDE Industry Task Force (Interim)
    • Real-World Evidence for Decision-Making
      • Narrative Review of Multi-Stakeholder Engagement in Health Technology Assessment

We provide a variety of resources that enable you to find, produce, interpret, and implement evidence. These include software applications, search tools, customized Excel spreadsheets, and more.

If you have any questions about our resources, please contact us at our main office.

  • Evidence Bundles
  • Finding the Evidence: Literature Searching Tools in Support of Systematic Reviews
  • HTA Excel Tools
  • Projects in Progress
  • Canadian Medical Imaging Inventory
  • Advisory Panel, Pan-Canadian Formulary
Share:
Copied to clipboard
Last Updated : March 26, 2022

Canada’s Drug Agency is a pan-Canadian health organization, created and funded by Canada’s federal, provincial, and territorial governments.

We provide Canada’s health system leaders with independent evidence and advice so they can make informed drug, health technology, and health system decisions, and we collaborate with national and international partners to enhance our collective impact. 

  • Reports
  • Contact
  • Careers
  • Help

Stay up to date on the latest from Canada’s Drug Agency by subscribing to our newsletter.

Already subscribed? Update your preferences.

  • visit us on facebook
  • visit us on linkedin
  • visit us on youtube
  • visit us on instagram

© 2025 Canadian Agency for Drugs and Technologies in Health

  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Request for Archived Report
Back to Top